感染性心内膜炎的诊断与治疗进展

朱云飞; 励峰

doi:10.11659/jjssx.11E022012

您当前的位置：

首页 >

文章列表页 >

感染性心内膜炎的诊断与治疗进展

综述 | 更新时间：2023-12-13

- 感染性心内膜炎的诊断与治疗进展
- Progress in the diagnosis and treatment of infective endocarditis
- 局解手术学杂志 2023年32卷第12期页码：1105-1111
- 作者机构：
  
  上海交通大学医学院附属第六人民医院/上海市第六人民医院心血管外科，上海 200233
- 作者简介：
  
  励峰，E-mail：cardiosh@ aliyun.com
- 基金信息：
  
  上海市科委科技创新行动计划(17411966600)
- DOI：10.11659/jjssx.11E022012
  中图分类号： R654.2
- 纸质出版日期：2023-12-25，
  
  收稿日期：2022-11-03，
扫描看全文
朱云飞,励峰.感染性心内膜炎的诊断与治疗进展[J].局解手术学杂志,2023,32(12):1105-1111.

ZHU Yun-fei,LI Feng.Progress in the diagnosis and treatment of infective endocarditis[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(12):1105-1111.
朱云飞,励峰.感染性心内膜炎的诊断与治疗进展[J].局解手术学杂志,2023,32(12):1105-1111. DOI： 10.11659/jjssx.11E022012.

ZHU Yun-fei,LI Feng.Progress in the diagnosis and treatment of infective endocarditis[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(12):1105-1111. DOI： 10.11659/jjssx.11E022012.

摘要

感染性心内膜炎（IE）是心内膜表面的一种感染性疾病，通常分为急性(症状持续在6周内)、亚急性(症状持续6周至3个月)和慢性(症状持续3个月以上)。IE是一种系统性疾病，其不仅累及心脏本身，还可影响全身多器官的功能。因此，IE的治疗需要多学科的共同参与，尤其是心胸外科、感染科和影像科。本研究对目前国内外关于IE的诊断与治疗的研究进展进行综述，以期为IE的诊治提供参考。

Abstract

Infective endocarditis （IE） is an infectious disease on the endocardial surface， which is usually divided into acute （symptoms last for 6 weeks）， sub-acute （symptoms last for 6 weeks to 3 months）， and chronic （symptoms last for more than 3 months）. IE is a systemic disease， which not only affects the heart itself， but also affects the function of multiple organs throughout the body. Therefore， the treatment of IE requires multidisciplinary involvement， especially the department of cardiothoracic surgery， infection department and imaging department. This study reviews the current research progress on the diagnosis and treatment of IE at home and abroad， in order to provide reference for the diagnosis and treatment of IE.

关键词

感染性心内膜炎进展多学科治疗

Keywords

infective endocarditisprogressmultidisciplinary therapy

references

Geller SA.Infective endocarditis：a history of the development of its understanding［J］.Autops Case Rep，2013，3（4）：5-12.doi：10.4322/acr.2013.033http://dx.doi.org/10.4322/acr.2013.033.

Tleyjeh IM，Steckelberg JM，Murad HS，et al.Temporal trends in infective endocarditis：a population-based study in Olmsted county，Minnesota［J］.JAMA，2005，293（24）：3022-3028.doi：10.1001/jama. 293.24.3022http://dx.doi.org/10.1001/jama.293.24.3022.

Wurcel AG，Anderson JE，Chui KK，et al.Increasing infectious endocarditis admissions among young people who inject drugs［J］.Open Forum Infect Dis，2016，3（3）：ofw157.doi：10.1093/ofid/ofw157http://dx.doi.org/10.1093/ofid/ofw157.

Yew HS，Murdoch DR.Global trends in infective endocarditis epidemiology［J］.Curr Infect Dis Rep，2012，14（4）：367-372.doi：10.1007/s11908-012-0265-5http://dx.doi.org/10.1007/s11908-012-0265-5.

Rwebembera J，Nascimento BR，Minja NW，et al.Recent advances in the rheumatic fever and rheumatic heart disease continuum［J］.Pathogens，2022，11（2）：179.doi：10.3390/pathogens11020179http://dx.doi.org/10.3390/pathogens11020179.

Vilacosta I，Graupner C，San Román JA，et al.Risk of embolization after institution of antibiotic therapy for infective endocarditis［J］.J Am Coll Cardiol，2002，39（9）：1489-1495.doi：10.1016/s0735-1097（02）01790-4http://dx.doi.org/10.1016/s0735-1097（02）01790-4.

Steckelberg JM，Murphy JG，Ballard D，et al.Emboli in infective endocarditis：the prognostic value of echocardiography［J］.Ann Intern Med，1991，114（8）：635-640.doi：10.7326/0003-4819-114-8-635http://dx.doi.org/10.7326/0003-4819-114-8-635.

Pawar NH，Nickalls OJ，Tan KL，et al.Invasive streptococcus pneumoniae infection causing cardioembolic stroke：a clinical proximity to austrian syndrome［J］.Cureus，2017，9（12）：e1960.doi：10.7759/cureus.1960http://dx.doi.org/10.7759/cureus.1960.

Murdoch DR，Corey GR，Hoen B，et al.Clinical presentation，etiology，and outcome of infective endocarditis in the 21st century：the International Collaboration on Endocarditis-Prospective Cohort Study［J］.Arch Intern Med，2009，169（5）：463-473.doi：10.1001/archinternmed.2008.603http://dx.doi.org/10.1001/archinternmed.2008.603.

JrFowler VG，Miro JM，Hoen B，et al.Staphylococcus aureus endocarditis：a consequence of medical progress［J］.JAMA，2005，293（24）：3012-3021.doi：10.1001/jama.293.24.3012http://dx.doi.org/10.1001/jama.293.24.3012.

Tattevin P，Watt G，Revest M，et al.Update on blood culture-negative endocarditis［J］.Med Mal Infect，2015，45（1/2）：1-8.doi：10.1016/j.medmal.2014.11.003http://dx.doi.org/10.1016/j.medmal.2014.11.003.

Fournier PE，Thuny F，Richet H，et al.Comprehensive diagnostic strategy for blood culture-negative endocarditis：a prospective study of 819 new cases［J］.Clin Infect Dis，2010，51（2）：131-140.doi：10.1086/653675http://dx.doi.org/10.1086/653675.

Bağ Soytaş R，Ünal D，Arman P，et al.Factors affecting mortality in geriatric patients hospitalized with COVID-19［J］.Turk J Med Sci，2021，51（2）：454-463.doi：10.3906/sag-2008-91http://dx.doi.org/10.3906/sag-2008-91.

Lecuit M，Eloit M.The diagnosis of infectious diseases by whole genome next generation sequencing：a new era is opening［J］.Front Cell Infect Microbiol，2014，4：25.doi：10.3389/fcimb.2014.00025http://dx.doi.org/10.3389/fcimb.2014.00025.

Yu X，Newland SA，Zhao TX，et al.Innate lymphoid cells promote recovery of ventricular function after myocardial infarction［J］.J Am Coll Cardiol，2021，78（11）：1127-1142.doi：10.1016/j.jacc. 2021.07.018http://dx.doi.org/10.1016/j.jacc.2021.07.018.

Baddour LM，Wilson WR，Bayer AS，et al.Infective endocarditis in adults：diagnosis，antimicrobial therapy，and management of complications：a scientific statement for healthcare professionals from the American heart association［J］.Circulation，2015，132（15）：1435-1486.doi：10.1161/CIR.0000000000000296http://dx.doi.org/10.1161/CIR.0000000000000296.

Habib G，Lancellotti P，Antunes MJ，et al.2015 ESC guidelines for the management of infective endocarditis：the task force for the management of infective endocarditis of the European Society of Cardiology （ESC）.Endorsed by：European Association for Cardio-Thoracic Surgery （EACTS），the European Association of Nuclear Medicine （EANM）［J］.Eur Heart J，2015，36（44）：3075-3128.doi：10.1093/eurheartj/ehv319http://dx.doi.org/10.1093/eurheartj/ehv319.

Mügge A，Daniel WG，Frank G，et al.Echocardiography in infective endocarditis：reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach［J］.J Am Coll Cardiol，1989，14（3）：631-638.doi：10.1016/0735-1097（89）90104-6http://dx.doi.org/10.1016/0735-1097（89）90104-6.

San Román JA，Vilacosta I.Role of transesophageal echocardiography in right-sided endocarditis［J］.Echocardiography，1995，12（6）：669-672.doi：10.1111/j.1540-8175.1995.tb00860.xhttp://dx.doi.org/10.1111/j.1540-8175.1995.tb00860.x.

American College of Cardiology Foundation Appropriate Use Criteria Task Force，American Society of Echocardiography，American Heart Association，et al.ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography.A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force，American Society of Echocardiography，American Heart Association，American Society of Nuclear Cardiology，Heart Failure Society of America，Heart Rhythm Society，Society for Cardiovascular Angiography and Interventions，Society of Critical Care Medicine，Society of Cardiovascular Computed Tomography，Society for Cardiovascular Magnetic Resonance American College of Chest Physicians［J］.J Am Soc Echocardiogr，2011，24（3）：229-267.doi：10.1016/j.echo.2010.12.008http://dx.doi.org/10.1016/j.echo.2010.12.008.

Doherty JU，Kort S，Mehran R，et al.ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease：a report of the American College of Cardiology Appropriate Use Criteria Task Force，American Association for Thoracic Surgery，American Heart Association，American Society of Echocardiography，American Society of Nuclear Cardiology，Heart Rhythm Society，Society for Cardiovascular Angiography and Interventions，Society of Cardiovascular Computed Tomography，Society for Cardiovascular Magnetic Resonance，and the Society of Thoracic Surgeons［J］.J Am Coll Cardiol，2019，73（4）：488-516.doi：10.1016/j.jacc.2018.10.038http://dx.doi.org/10.1016/j.jacc.2018.10.038.

Gadhinglajkar S，Sreedhar R，Karunakaran J，et al.Tricuspid valve excision using off-pump inflow occlusion technique：role of intra-operative trans-esophageal echocardiography［J］.Ann Card Anaesth，2010，13（2）：148-153.doi：10.4103/0971-9784.62929http://dx.doi.org/10.4103/0971-9784.62929.

Eltzschig HK，Rosenberger P，Loffler M，et al.Impact of intraoperative transesophageal echocardiography on surgical decisions in 12，566 patients undergoing cardiac surgery［J］.Ann Thorac Surg，2008，85（3）：845-852.doi：10.1016/j.athoracsur.2007.11.015http://dx.doi.org/10.1016/j.athoracsur.2007.11.015.

Emily J，MacKay DO，Bo Zhang，et al.Association of intraoperative transesophageal echocardiography and clinical outcomes after open cardiac valve or proximal aortic surgery［J］.JAMA Netw Open，2022，5（2）：e2147820.doi：10.1001/jamanetworkopen.2021.47820http://dx.doi.org/10.1001/jamanetworkopen.2021.47820.

Hansalia S，Biswas M，Dutta R，et al.The value of live/real time three-dimensional transesophageal echocardiography in the assessment of valvular vegetations［J］.Echocardiography，2009，26（10）：1264-1273.doi：10.1111/j.1540-8175.2009.01042.xhttp://dx.doi.org/10.1111/j.1540-8175.2009.01042.x.

Saxena P，Malouf JF，Click R，et al.3D echocardiography in cardiac surgery［J］.J Card Surg，2014，29（1）：51-54.doi：10.1111/jocs.12256http://dx.doi.org/10.1111/jocs.12256.

Narducci ML，Pelargonio G，Russo E，et al.Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis［J］.J Am Coll Cardiol，2013，61（13）：1398-1405.doi：10.1016/j.jacc.2012.12.041http://dx.doi.org/10.1016/j.jacc.2012.12.041.

Feuchtner GM，Stolzmann P，Dichtl W，et al.Multislice computed tomography in infective endocarditis：comparison with transesophageal echocardiography and intraoperative findings［J］.J Am Coll Cardiol，2009，53（5）：436-444.doi：10.1016/j.jacc.2008.01.077http://dx.doi.org/10.1016/j.jacc.2008.01.077.

Hryniewiecki T，Zatorska K，Abramczuk E，et al.The usefulness of cardiac CT in the diagnosis of perivalvular complications in patients with infective endocarditis［J］.Eur Radiol，2019，29（8）：4368-4376.doi：10.1007/s00330-018-5965-2http://dx.doi.org/10.1007/s00330-018-5965-2.

Kim IC，Chang S，Hong GR，et al.Comparison of cardiac computed tomography with transesophageal echocardiography for identifying vegetation and intracardiac complications in patients with infective endocarditis in the era of 3-dimensional images［J］.Circ Cardiovasc Imaging，2018，11（3）：e006986.doi：10.1161/CIRCIMAGING. 117.006986http://dx.doi.org/10.1161/CIRCIMAGING.117.006986.

Duval X，Iung B，Klein I，et al.Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis：a prospective study［J］.Ann Intern Med，2010，152（8）：497-504.doi：10.7326/0003-4819-152-8-201004200-00006http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00006.

Saby L，Laas O，Habib G，et al.Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis：increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion［J］.J Am Coll Cardiol，2013，61（23）：2374-2382.doi：10.1016/j.jacc.2013.01.092http://dx.doi.org/10.1016/j.jacc.2013.01.092.

Kestler M，Muñoz P，Rodríguez-Créixems M，et al.Group for the Management of Infectious Endocarditis （GAME）.Role of （18）F-FDG PET in patients with infectious endocarditis［J］.J Nucl Med，2014，55（7）：1093-1098.doi：10.2967/jnumed.113.134981http://dx.doi.org/10.2967/jnumed.113.134981.

Jiménez-Ballvé A，Pérez-Castejón MJ，Delgado-Bolton RC，et al.Assessment of the diagnostic accuracy of 18F-FDG PET/CT in prosthetic infective endocarditis and cardiac implantable electronic device infection：comparison of different interpretation criteria［J］.Eur J Nucl Med Mol Imaging，2016，43（13）：2401-2412.doi：10.1007/s00259-016-3463-9http://dx.doi.org/10.1007/s00259-016-3463-9.

Durack DT，Lukes AS，Bright DK.New criteria for diagnosis of infective endocarditis：utilization of specific echocardiographic findings.Duke Endocarditis Service［J］.Am J Med，1994，96（3）：200-209.doi：10.1016/0002-9343（94）90143-0http://dx.doi.org/10.1016/0002-9343（94）90143-0.

Li JS，Sexton DJ，Mick N，et al.Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis［J］.Clin Infect Dis，2000，30（4）：633-638.doi：10.1086/313753http://dx.doi.org/10.1086/313753.

Habib G，Derumeaux G，Avierinos JF，et al.Value and limitations of the Duke criteria for the diagnosis of infective endocarditis［J］.J Am Coll Cardiol，1999，33（7）：2023-2029.doi：10.1016/s0735-1097（99）00116-3http://dx.doi.org/10.1016/s0735-1097（99）00116-3.

Francioli P，Etienne J，Hoigné R，et al.Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks：efficacy and outpatient treatment feasibility［J］.JAMA，1992，267（2）：264-267.doi：10.1001/jama.1992.03480020074034http://dx.doi.org/10.1001/jama.1992.03480020074034.

Verhagen DW，Vedder AC，Speelman P，et al.Antimicrobial treatment of infective endocarditis caused by viridans streptococci highly susceptible to penicillin：historic overview and future considerations［J］.J Antimicrob Chemother，2006，57（5）：819-884.doi：10.1093/jac/dkl087http://dx.doi.org/10.1093/jac/dkl087.

JrFowler VG，Boucher HW，Corey GR，et al.Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus［J］.N Engl J Med，2006，355（7）：653-665.doi：10.1056/NEJMoa053783http://dx.doi.org/10.1056/NEJMoa053783.

Carugati M，Bayer AS，Miró JM，et al.International collaboration on endocarditis.High-dose daptomycin therapy for left-sided infective endocarditis：a prospective study from the international collaboration on endocarditis［J］.Antimicrob Agents Chemother，2013，57（12）：6213-6222.doi：10.1128/AAC.01563-13http://dx.doi.org/10.1128/AAC.01563-13.

Kiefer T，Park L，Tribouilloy C，et al.Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure［J］.JAMA，2011，306（20）：2239-2247.doi：10.1001/jama.2011.1701http://dx.doi.org/10.1001/jama.2011.1701.

Remadi JP，Habib G，Nadji G，et al.Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis［J］.Ann Thorac Surg，2007，83（4）：1295-1302.doi：10.1016/j.athoracsur. 2006.09.093http://dx.doi.org/10.1016/j.athoracsur.2006.09.093.

Hill EE，Herijgers P，Claus P，et al.Abscess in infective endocarditis：the value of transesophageal echocardiography and outcome：a 5-year study［J］.Am Heart J，2007，154（5）：923-928.doi：10.1016/j.ahj.2007.06.028http://dx.doi.org/10.1016/j.ahj.2007.06.028.

Sohail MR，Martin KR，Wilson WR，et al.Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis［J］.Am J Med，2006，119（2）：147-154.doi：10.1016/j.amjmed. 2005.09.037http://dx.doi.org/10.1016/j.amjmed.2005.09.037.

Fosbøl EL，Park LP，Chu VH，et al.The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis［J］.Eur Heart J，2019，40（27）：2243-2251.doi：10.1093/eurheartj/ehz204http://dx.doi.org/10.1093/eurheartj/ehz204.

García-Cabrera E，Fernández-Hidalgo N，Almirante B，et al.Neurological complications of infective endocarditis：risk factors，outcome，and impact of cardiac surgery：a multicenter observational study［J］.Circulation，2013，127（23）：2272-2284.doi：10.1161/CIRCULATIO NAHA.112.000813http://dx.doi.org/10.1161/CIRCULATIONAHA.112.000813.

Voigt A，Shalaby A，Saba S.Continued rise in rates of cardiovascular implantable electronic device infections in the United States：temporal trends and causative insights［J］.Pacing Clin Electrophysiol，2010，33（4）：414-419.doi：10.1111/j.1540-8159.2009.02569.xhttp://dx.doi.org/10.1111/j.1540-8159.2009.02569.x.

Blomström-Lundqvist C，Traykov V，Erba PA，et al.European Heart Rhythm Association （EHRA） international consensus document on how to prevent，diagnose，and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society （HRS），the Asia Pacific Heart Rhythm Society （APHRS），the Latin American Heart Rhythm Society （LAHRS），International Society for Cardiovascular Infectious Diseases （ISCVID） and the European Society of Clinical Microbiology and Infectious Diseases （ESCMID） in collaboration with the European Association for Cardio-Thoracic Surgery （EACTS）［J］.Europace，2020，22（4）：515-549.doi：10.1093/europace/euz246http://dx.doi.org/10.1093/europace/euz246.

Victor F，De Place C，Camus C，et al.Pacemaker lead infection：echocardiographic features，management，and outcome［J］.Heart，1999，81（1）：82-87.doi：10.1136/hrt.81.1.82http://dx.doi.org/10.1136/hrt.81.1.82.

Chrapko BE，Chrapko M，Nocuń A，et al.Role of 18F-FDG PET/CT in the diagnosis of inflammatory and infectious vascular disease［J］.Nucl Med Rev Cent East Eur，2016，19（1）：28-36.doi：10.5603/NMR.2016.0006http://dx.doi.org/10.5603/NMR.2016.0006.

Slaughter MS，Rogers JG，Milano CA，et al.Advanced heart failure treated with continuous-flow left ventricular assist device［J］.N Engl J Med，2009，361（23）：2241-2251.doi：10.1056/NEJMoa0909938http://dx.doi.org/10.1056/NEJMoa0909938.

Nienaber J，Wilhelm MP，Sohail MR.Current concepts in the diagnosis and management of left ventricular assist device infections［J］.Expert Rev Anti Infect Ther，2013，11（2）：201-210.doi：10.1586/eri.12.163http://dx.doi.org/10.1586/eri.12.163.

Patel S，Rizvi SSA，Choi JH，et al.Management and outcomes of left ventricular assist device-associated endocarditis：a systematic review［J］.Ann Cardiothorac Surg，2019，8（6）：600-609.doi：10.21037/acs.2019.04.04http://dx.doi.org/10.21037/acs.2019.04.04.

Summers MR，Leon MB，Smith CR，et al.Prosthetic valve endocarditis after TAVR and SAVR：insights from the PARTNER trials［J］.Circulation，2019，140（24）：1984-1994.doi：10.1161/CIRCULATIO NAHA.119.041399http://dx.doi.org/10.1161/CIRCULATIONAHA.119.041399.

Slesnick TC，Nugent AW，JrFraser CD，et al.Images in cardiovascular medicine.Incomplete endothelialization and late development of acute bacterial endocarditis after implantation of an Amplatzer septal occluder device［J］.Circulation，2008，17（18）：e326-e327.doi：10.1161/CIRCULATIONAHA.107.754069http://dx.doi.org/10.1161/CIRCULATIONAHA.107.754069.

Montoya ME，Karnath BM，Ahmad M.Endocarditis during pregnancy［J］.South Med J，2003，96（11）：1156-1157.doi：10.1097/01.SMJ. 0000054503.18393.1Ehttp://dx.doi.org/10.1097/01.SMJ.0000054503.18393.1E.

Campuzano K，Roqué H，Bolnick A，et al.Bacterial endocarditis complicating pregnancy：case report and systematic review of the literature［J］.Arch Gynecol Obstet，2003，268（4）：251-255.doi：10.1007/s00404-003-0485-xhttp://dx.doi.org/10.1007/s00404-003-0485-x

Kaoutzanis C，Evangelakis E，Kokkinos C，et al.Urgent aortic valve replacement for infective endocarditis during the 23rd week of pregnancy［J］.Gen Thorac Cardiovasc Surg，2013，61（5）：296-300.doi：10.1007/s11748-012-0140-1http://dx.doi.org/10.1007/s11748-012-0140-1.

Ramlakhan KP，Johnson MR，Roos-Hesselink JW.Pregnancy and cardiovascular disease［J］.Nat Rev Cardiol，2020，17（11）：718-731.doi：10.1038/s41569-020-0390-zhttp://dx.doi.org/10.1038/s41569-020-0390-z.

Bor DH，Woolhandler S，Nardin R，et al.Infective endocarditis in the U.S.，1998-2009：a nationwide study［J］.PLoS One，2013，8（3）：e60033.doi：10.1371/journal.pone.0060033http://dx.doi.org/10.1371/journal.pone.0060033.

Sorabella RA，Han SM，Grbic M，et al.Early operation for endocarditis complicated by preoperative cerebral emboli is not associated with worsened outcomes［J］.Ann Thorac Surg，2015，100（2）：501-508.doi：10.1016/j.athoracsur.2015.03.078http://dx.doi.org/10.1016/j.athoracsur.2015.03.078.

Kitai T，Masumoto A，Okada T，et al.Optimal timing of surgery for patients with active infective endocarditis［J］.Cardiol Clin，2021，39（2）：197-209.doi：10.1016/j.ccl.2021.01.002http://dx.doi.org/10.1016/j.ccl.2021.01.002.

Thuny F，Avierinos JF，Tribouilloy C，et al.Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis：a prospective multicentre study［J］.Eur Heart J，2007，28（9）：1155-1161.doi：10.1093/eurheartj/ehm005http://dx.doi.org/10.1093/eurheartj/ehm005.

Yanagawa B，Pettersson GB，Habib G，et al.Surgical management of infective endocarditis complicated by embolic stroke：practical recommendations for clinicians［J］.Circulation，2016，134（17）：1280-1292.doi：10.1161/CIRCULATIONAHA.116.024156http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024156.

Tam DY，Yanagawa B，Verma S，et al.Early vs. late surgery for patients with endocarditis and neurological injury：a systematic review and meta-analysis［J］.Can J Cardiol，2018，34（9）：1185-1199.doi：10.1016/j.cjca.2018.05.010http://dx.doi.org/10.1016/j.cjca.2018.05.010.

Gaca JG，Sheng S，Daneshmand M，et al.Current outcomes for tricuspid valve infective endocarditis surgery in North America［J］.Ann Thorac Surg，2013，96（4）：1374-1381.doi：10.1016/j.athoracsur.2013.05.046http://dx.doi.org/10.1016/j.athoracsur.2013.05.046.

Akinosoglou K，Apostolakis E，Koutsogiannis N，et al.Right-sided

infective endocarditis：surgical management［J］.Eur J Cardiothorac Surg，2012，42（3）：470-479.doi：10.1093/ejcts/ezs084http://dx.doi.org/10.1093/ejcts/ezs084.

Tornos P，Almirante B，Mirabet S，et al.Infective endocarditis due to Staphylococcus aureus：deleterious effect of anticoagulant therapy［J］.Arch Intern Med，1999，159（5）：473-475.doi：10.1001/archinte. 159.5.473http://dx.doi.org/10.1001/archinte.159.5.473.

Papazian L，Roch A，Charles PE，et al.Effect of statin therapy on mortality in patients with ventilator-associated pneumonia：a randomized clinical trial［J］.JAMA，2013，310（16）：1692-1700.doi：10.1001/jama.2013.280031http://dx.doi.org/10.1001/jama.2013.280031.

The Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease， American Heart Association.TREATMENT of acute rheumatic fever in children a co-operative clinical trial of A.C.T.H.，cortisone，and aspirin［J］.Br Med J，1955，1（4913）：555-574.

Kerdemelidis M，Lennon DR，Arroll B，et al.The primary prevention of rheumatic fever［J］.J Paediatr Child Health，2010，46（9）：534-548.doi：10.1111/j.1440-1754.2010.01854.xhttp://dx.doi.org/10.1111/j.1440-1754.2010.01854.x.

Wilson W，Taubert KA，Gewitz M，et al.Prevention of infective endocarditis：guidelines from the American Heart Association：a guideline from the American Heart Association Rheumatic Fever，Endocarditis and Kawasaki Disease Committee，Council on Cardiovascular Disease in the Young，and the Council on Clinical Cardiology，Council on Cardiovascular Surgery and Anesthesia，and the Quality of Care and Outcomes Research Interdisciplinary Working Group［J］.J Am Dent Assoc，2007，138（6）：739-745.doi：10.14219/jada.archive. 2007.0262http://dx.doi.org/10.14219/jada.archive.2007.0262.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

感染性心内膜炎细胞因子和降钙素原的表达